• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results

    12/26/24 3:18:00 AM ET
    $IH
    Other Consumer Services
    Real Estate
    Get the next $IH alert in real time by email

    BEIJING, Dec. 26, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2024.  

    (PRNewsfoto/iHuman Inc.)

    Third Quarter 2024 Highlights

    • Revenues were RMB239.4 million (US$34.1 million), compared with RMB261.5 million in the same period last year.
    • Gross profit was RMB163.9 million (US$23.4 million), compared with RMB186.6 million in the same period last year.
    • Operating income was RMB20.7 million (US$2.9 million), compared with RMB40.4 million in the same period last year.
    • Net income was RMB25.1 million (US$3.6 million), compared with RMB51.9 million in the same period last year.
    • Average total MAUs[1] reached a record-high of 29.12 million, a year-over-year increase of 14.8%.

    [1] "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.

    Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, "In the third quarter, we continued to see robust user demand for our products, driving average total MAUs to another record high of 29.12 million, representing a year-over-year increase of 14.8%. This growth underscores the effectiveness of our product strategy focused on innovation, overseas market expansion, and responsiveness to evolving market dynamics.

    Domestically, we further strengthened our market leadership by enhancing our product portfolio with the launch of iHuman Chinese Reading. This new offering aims to cultivate an interest in Chinese reading, enhance literacy and verbal skills, and deepen children's understanding of the Chinese culture. Developed by the same team behind our highly acclaimed iHuman Chinese app, iHuman Chinese Reading continues our proud tradition and commitment to excellent content and innovative design. The course features a leveled reading system that facilitates gradual progress in Chinese proficiency and offers a rich variety of content formats, such as ancient Chinese poems, interactive storybooks, and online study tours.

    Building on our foundation, we expanded our content library by strengthening ties with influential industry players and leveraged our advanced technology to create richer and more immersive experiences for children. For instance, through our previously announced strategic partnership with Children's Fun Publishing Co. Ltd., a leading children's book publisher in China, we recently launched a new "Frozen" theme within iHuman Little Artists, where children can color their favorite Frozen characters and scenes, upload their artwork, and watch them come to life in a narrated storybook. This integration provides children with a creative way to experience the popular Frozen story while offering a highly interactive reading and drawing experience.

    We also continued to roll out updates across other app products. For example, we added two new themes to iHuman Magic Thinking: "Sudoku" and "Thinking Logic." "Sudoku" introduces children to Sudoku rules and mathematical concepts through short, animated stories and interactive challenges, and "Thinking Logic" engages them with a detective story series designed to sharpen judgment, analytical thinking, and problem-solving abilities.

    On the international front, we enriched our portfolio with fresh content and features to boost user engagement and expand our global reach. Aha World received several updates, adding even more fun and adventure to its ever-expanding fantasy world. Children can now explore the "Love Animal Shelter," where they can adopt, wash, and care for adorable virtual pets and enjoy an immersive and joyful pet ownership experience. For those captivated by the mystical, we introduced themes like "Magic School" and "Magic Street," which take children on enchanting adventures and introduce magical shops filled with delightful surprises. These efforts have further boosted Aha World's popularity. By the end of September, Aha World achieved over 502 million cumulative views across various social media platforms and attracted more than 1.4 million followers globally, reflecting its growing appeal among young users worldwide. 

    Looking ahead, we remain focused on enhancing our diverse portfolio across markets to better promote children's holistic development while advancing our sustainable growth initiatives," concluded Dr. Dai.

    Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "In the third quarter of 2024, we achieved our eleventh consecutive quarter of profitability, with net income reaching RMB25.1 million. This sustained financial strength enables us to continue expanding our impact across diverse channels and customer segments. For instance, our animation studio, Kunpeng, broadened its product lineup with the launch of a new animated series, "Rainbow Crew," in October. The new series swiftly gained traction following its release, topping the charts for children's shows on leading streaming platforms, including Tencent Video, iQIYI, and Youku.

    Beyond consumer-facing products, we have also built a robust B2B model that currently supports nearly 10,000 kindergartens and institutions across China. Our tailored content resources and solutions empower these institutions with a comprehensive suite of diverse, ready-to-use products that effectively meet the developmental needs of young children, promoting the high-quality development of kindergartens and institutions. Recently, we have opened an experience center in Zhongshan, Guangdong Province, which combines education, entertainment, hands-on experience, and some unique features. Designed as a one-stop demonstration hub for institutional customers and vendors, the center is organized into six key areas—core content, specialty content, extended services, a multi-functional hall, indoor play spaces, and outdoor activity zones—showcasing our interactive products and innovative approach to supporting early childhood development in a kindergarten setting. This hands-on experience enables institutions to gain a deeper understanding of how our offerings can seamlessly integrate into their educational environments. Moving forward, we will leverage our solid financial foundation and innovative product ecosystem to deepen our impact in both the consumer and business segments, reinforcing our industry-leading position and creating value for our shareholders."

    Third Quarter 2024 Unaudited Financial Results

    Revenues

    Revenues were RMB239.4 million (US$34.1 million), a decrease of 8.4% from RMB261.5 million in the same period last year, primarily due to more conservative consumer spending. 

    Average total MAUs for the quarter were 29.12 million, an increase of 14.8% year-over-year from 25.36 million in the same period last year, primarily due to the effective execution of our user acquisition strategy and ongoing product innovation.

    Cost of Revenues

    Cost of revenues was RMB75.5 million (US$10.8 million), compared with RMB74.9 million in the same period last year.

    Gross Profit and Gross Margin

    Gross profit was RMB163.9 million (US$23.4 million), compared with RMB186.6 million in the same period last year. Gross margin was 68.4%, compared with 71.4% in the same period last year. The slight decrease in gross margin was mainly due to our increased focus on the offline component in the integrated online-offline product strategy to enhance the attractiveness of the product.

    Operating Expenses

    Total operating expenses were RMB143.2 million (US$20.4 million), compared to RMB146.2 million in the same period last year.

    Research and development expenses were RMB59.3 million (US$8.5 million), a decrease of 10.4% from RMB66.2 million in the same period last year, primarily due to savings in payroll related expenses.  

    Sales and marketing expenses were RMB60.9 million (US$8.7 million), an increase of 12.7% from RMB54.0 million in the same period last year, primarily due to increased strategic spending on promotional activities, brand enhancement, and overseas expansion.

    General and administrative expenses were RMB23.0 million (US$3.3 million), a decrease of 11.8% from RMB26.1 million in the same period last year, primarily due to savings in payroll related expenses, share-based compensation expenses, as well as other administrative expenses. 

    Operating Income

    Operating income was RMB20.7 million (US$2.9 million), compared with RMB40.4 million in the same period last year.

    Net Income

    Net income was RMB25.1 million (US$3.6 million), compared with RMB51.9 million in the same period last year.

    Basic and diluted net income per ADS were RMB0.48 (US$0.07) and RMB0.47 (US$0.07), respectively, compared with RMB0.98 and RMB0.95 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

    Deferred Revenue and Customer Advances

    Deferred revenue and customer advances were RMB298.9 million (US$42.6 million) as of September 30, 2024, compared with RMB318.6 million as of December 31, 2023.

    Cash, Cash Equivalents and Short-term Investments

    Cash, cash equivalents and short-term investments were RMB1,168.6 million (US$166.5 million) as of September 30, 2024, compared with RMB1,213.8 million as of December 31, 2023.

    Extension of Share Repurchase Program

    Given its confidence in the Company's business prospects, the board of directors (the "Board") has authorized an extension of the Company's existing share repurchase program, as authorized in December 2021 and extended to remain effective to the end of December 2024, by another twelve months through December 31, 2025. Pursuant to the extended share repurchase program, the Company's proposed repurchases may be made from time to time through open market transactions at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on the market conditions and in accordance with applicable rules and regulations. The timing and dollar amount of repurchase transactions will be subject to the Securities and Exchange Commission Rule 10b-18 and Rule 10b5-1 requirements. The Board will continue to review the extended share repurchase program periodically, and may authorize adjustments to its terms and size. The Company expects to continue to fund the repurchases under the extended share repurchase program with its existing cash balance.

    Exchange Rate Information

    The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of September 30, 2024, which was RMB7.0176 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

    Non-GAAP Financial Measures

    iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman's management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company's current operating performance and prospects in the same manner as management does, if they so choose.

    Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

    Safe Harbor Statement

    This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    About iHuman Inc.

    iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

    For more information about iHuman, please visit https://ir.ihuman.com/.

    For investor and media enquiries, please contact:

    iHuman Inc.

    Mr. Justin Zhang

    Investor Relations Director

    Phone: +86 10 5780-6606

    E-mail: [email protected] 

    Christensen

    In China

    Ms. Alice Li

    Phone: +86-10-5900-1548

    E-mail: [email protected]  

    In the US

    Ms. Linda Bergkamp

    Phone: +1-480-614-3004

    E-mail: [email protected] 

     

     

    iHuman Inc.

    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS



    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    December 31,



    September 30,



    September 30,



    2023



    2024



    2024



    RMB



    RMB



    US$













    ASSETS











    Current assets











    Cash and cash equivalents 

    1,213,767



    651,684



    92,864

    Short-term investments

    -



    516,910



    73,659

    Accounts receivable, net

    60,832



    66,376



    9,459

    Inventories, net

    16,518



    16,882



    2,406

    Amounts due from related parties

    1,810



    2,099



    299

    Prepayments and other current assets

    89,511



    102,036



    14,540

    Total current assets

    1,382,438



    1,355,987



    193,227

    Non-current assets











    Property and equipment, net

    6,169



    3,893



    555

    Intangible assets, net

    23,245



    21,121



    3,010

    Operating lease right-of-use assets

    3,648



    2,376



    339

    Long-term investment

    26,333



    26,333



    3,752

    Other non-current assets

    8,662



    10,937



    1,556

    Total non-current assets

    68,057



    64,660



    9,212

    Total assets

    1,450,495



    1,420,647



    202,439













    LIABILITIES











    Current liabilities











    Accounts payable

    22,139



    25,761



    3,671

    Deferred revenue and customer advances

    318,587



    298,896



    42,592

    Amounts due to related parties

    4,428



    20,719



    2,952

    Accrued expenses and other current liabilities

    143,677



    116,382



    16,584

    Dividend payable

    -



    30,139



    4,295

    Current operating lease liabilities

    1,927



    1,683



    240

    Total current liabilities

    490,758



    493,580



    70,334

    Non-current liabilities











    Non-current operating lease liabilities

    1,933



    735



    105

    Total non-current liabilities

    1,933



    735



    105

    Total liabilities

    492,691



    494,315



    70,439

    SHAREHOLDERS' EQUITY











    Ordinary shares (par value of US$0.0001 per share,

        700,000,000 Class A shares authorized as of

        December 31, 2023 and September 30, 2024;

        125,122,382 Class A shares issued and 119,704,787

        outstanding as of December 31, 2023; 125,122,382

        Class A shares issued and 117,107,067 outstanding as

        of September 30, 2024; 200,000,000 Class B shares

        authorized, 144,000,000 Class B ordinary shares

        issued and outstanding as of December 31, 2023 and

        September 30, 2024; 100,000,000 shares

        (undesignated) authorized, nil shares (undesignated)

        issued and outstanding as of December 31, 2023 and

        September 30, 2024)

    185



    185



    26

    Additional paid-in capital

    1,088,628



    996,089



    141,942

    Treasury stock

    (16,665)



    (23,579)



    (3,360)

    Statutory reserves

    8,164



    8,164



    1,163

    Accumulated other comprehensive income

    17,955



    13,828



    1,970

    Accumulated deficit

    (140,463)



    (68,355)



    (9,741)

    Total shareholders' equity

    957,804



    926,332



    132,000

    Total liabilities and shareholders' equity

    1,450,495



    1,420,647



    202,439

     

     

    iHuman Inc.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS



    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    For the three months ended



    For the nine months ended



    September 30,



    June 30,



    September 30,



    September 30,



    September 30,



    September 30,



    September 30,



    2023



    2024



    2024



    2024



    2023



    2024



    2024



    RMB



    RMB



    RMB



    US$



    RMB



    RMB



    US$





























    Revenues

    261,496



    215,107



    239,407



    34,115



    767,692



    689,517



    98,255

    Cost of revenues

    (74,871)



    (63,372)



    (75,541)



    (10,765)



    (224,667)



    (205,805)



    (29,327)





























    Gross profit

    186,625



    151,735



    163,866



    23,350



    543,025



    483,712



    68,928





























    Operating expenses



























    Research and development expenses

    (66,168)



    (57,219)



    (59,307)



    (8,451)



    (191,253)



    (184,449)



    (26,284)

    Sales and marketing expenses

    (53,994)



    (51,263)



    (60,863)



    (8,673)



    (134,993)



    (167,121)



    (23,815)

    General and administrative expenses

    (26,070)



    (24,426)



    (22,998)



    (3,277)



    (78,787)



    (75,148)



    (10,709)

    Total operating expenses

    (146,232)



    (132,908)



    (143,168)



    (20,401)



    (405,033)



    (426,718)



    (60,808)

    Operating income

    40,393



    18,827



    20,698



    2,949



    137,992



    56,994



    8,120

    Other income, net

    19,507



    9,410



    8,024



    1,143



    33,721



    26,444



    3,768

    Income before income taxes

    59,900



    28,237



    28,722



    4,092



    171,713



    83,438



    11,888

    Income tax expenses

    (7,984)



    (3,574)



    (3,579)



    (510)



    (24,077)



    (11,330)



    (1,615)

    Net income

    51,916



    24,663



    25,143



    3,582



    147,636



    72,108



    10,273





























    Net income per ADS:



























       - Basic

    0.98



    0.47



    0.48



    0.07



    2.79



    1.37



    0.20

       - Diluted

    0.95



    0.45



    0.47



    0.07



    2.70



    1.33



    0.19





























    Weighted average number of ADSs:



























       - Basic

    52,747,426



    52,496,541



    52,283,334



    52,283,334



    52,834,352



    52,502,206



    52,502,206

       - Diluted

    54,772,536



    54,295,419



    54,011,420



    54,011,420



    54,753,124



    54,332,011



    54,332,011





























    Total share-based compensation expenses included in:



























    Cost of revenues

    67



    26



    22



    3



    235



    88



    13

    Research and development expenses

    1,160



    348



    225



    32



    2,940



    1,030



    147

    Sales and marketing expenses

    147



    45



    39



    6



    585



    130



    19

    General and administrative expenses

    1,105



    392



    329



    47



    3,557



    1,022



    146





























     

     

    iHuman Inc.

    UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS



    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    For the three months ended



    For the nine months ended



    September 30,



    June 30,



    September 30,



    September 30,



    September 30,



    September 30,



    September 30,



    2023



    2024



    2024



    2024



    2023



    2024



    2024



    RMB



    RMB



    RMB



    US$



    RMB



    RMB



    US$





























    Operating income

    40,393



    18,827



    20,698



    2,949



    137,992



    56,994



    8,120

    Share-based compensation expenses

    2,479



    811



    615



    88



    7,317



    2,270



    325

    Adjusted operating income

    42,872



    19,638



    21,313



    3,037



    145,309



    59,264



    8,445





























    Net income

    51,916



    24,663



    25,143



    3,582



    147,636



    72,108



    10,273

    Share-based compensation expenses

    2,479



    811



    615



    88



    7,317



    2,270



    325

    Adjusted net income

    54,395



    25,474



    25,758



    3,670



    154,953



    74,378



    10,598





























    Diluted net income per ADS

    0.95



    0.45



    0.47



    0.07



    2.70



    1.33



    0.19

    Impact of non-GAAP adjustments

    0.04



    0.02



    0.01



    0.00



    0.13



    0.04



    0.01

    Adjusted diluted net income per ADS

    0.99



    0.47



    0.48



    0.07



    2.83



    1.37



    0.20





























    Weighted average number of ADSs – diluted

    54,772,536



    54,295,419



    54,011,420



    54,011,420



    54,753,124



    54,332,011



    54,332,011

    Weighted average number of ADSs – adjusted

    54,772,536



    54,295,419



    54,011,420



    54,011,420



    54,753,124



    54,332,011



    54,332,011

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-third-quarter-2024-unaudited-financial-results-302339217.html

    SOURCE iHuman Inc.

    Get the next $IH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IH

    DatePrice TargetRatingAnalyst
    12/30/2022$3.10Buy
    Citigroup
    More analyst ratings

    $IH
    SEC Filings

    See more
    • SEC Form 20-F filed by iHuman Inc.

      20-F - iHuman Inc. (0001814423) (Filer)

      4/28/25 4:01:23 PM ET
      $IH
      Other Consumer Services
      Real Estate
    • SEC Form 6-K filed by iHuman Inc.

      6-K - iHuman Inc. (0001814423) (Filer)

      3/25/25 7:10:38 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • SEC Form 6-K filed by iHuman Inc.

      6-K - iHuman Inc. (0001814423) (Filer)

      12/26/24 6:01:05 AM ET
      $IH
      Other Consumer Services
      Real Estate

    $IH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Citigroup resumed coverage on iHuman with a new price target

      Citigroup resumed coverage of iHuman with a rating of Buy and set a new price target of $3.10

      12/30/22 8:45:58 AM ET
      $IH
      Other Consumer Services
      Real Estate

    $IH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

      SC 13G/A - iHuman Inc. (0001814423) (Subject)

      3/8/22 10:06:04 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

      SC 13G/A - iHuman Inc. (0001814423) (Subject)

      2/14/22 4:13:25 PM ET
      $IH
      Other Consumer Services
      Real Estate
    • SEC Form SC 13G filed

      SC 13G - iHuman Inc. (0001814423) (Subject)

      2/16/21 6:11:44 AM ET
      $IH
      Other Consumer Services
      Real Estate

    $IH
    Financials

    Live finance-specific insights

    See more

    $IH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • iHuman Inc. Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results

      BEIJING, March 25, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Revenues were RMB232.7 million (US$31.9 million), compared with RMB250.4 million in the same period last year.Gross profit was RMB156.4 million (US$21.4 million), compared with RMB178.2 million in the same period last year.Operating income was RMB14.9 million (US$2.0 m

      3/25/25 4:03:00 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • iHuman Inc. Announces Third Quarter 2024 Unaudited Financial Results

      BEIJING, Dec. 26, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2024.   Third Quarter 2024 Highlights Revenues were RMB239.4 million (US$34.1 million), compared with RMB261.5 million in the same period last year.Gross profit was RMB163.9 million (US$23.4 million), compared with RMB186.6 million in the same period last year.Operating income was RMB20.7 million (US$2.9 million), compare

      12/26/24 3:18:00 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • iHuman Inc. Announces Second Quarter 2024 Unaudited Financial Results

      BEIJING, Sept. 27, 2024 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Highlights Revenues were RMB215.1 million (US$29.6 million), compared with RMB241.0 million in the same period last year.Gross profit was RMB151.7 million (US$20.9 million), compared with RMB170.8 million in the same period last year.Operating income was RMB18.8 million (US$2.6 million), compared wi

      9/27/24 5:47:00 AM ET
      $IH
      Other Consumer Services
      Real Estate
    • UPDATE - International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

      NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Thursday, May 15, 2025 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States. Representatives from participating companies based in China, Hong Kong, Philippines, Denmark, Germany, South Africa, Switzerland, Sweden, and the United Kingdom will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies. There is no fee for participants to log in, attend live pr

      5/8/25 10:44:07 AM ET
      $BLTE
      $COE
      $HCM
      $IH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Other Consumer Services
      Real Estate
    • International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15, 2025

      NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on Thursday, May 15, 2025 featuring live webcast presentations from international companies with American Depositary Receipt (ADR) programs in the United States. Representatives from participating companies based in China, Hong Kong, Philippines, Denmark, Germany, South Africa, Switzerland, Sweden, and the United Kingdom will respond to questions during formal presentations. The conference is targeted to all categories of investors and analysts interested in international companies. There is no fee for participants to log in, attend live pr

      5/8/25 8:35:00 AM ET
      $BLTE
      $COE
      $HCM
      $IH
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Other Consumer Services
      Real Estate
    • iHuman Inc. Files 2024 Annual Report on Form 20-F

      BEIJING, April 28, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission on April 28, 2025. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/. iHuman will provide a hard copy of its annual report on Form 20-F containing complete audited financial statements for the year ended December 31, 2024, free of charge, to its shareholders and ADS holders upon request. Requests should be directed t

      4/28/25 4:40:00 PM ET
      $IH
      Other Consumer Services
      Real Estate